Scanogen
Windsor Mill
About Scanogen
Single Molecule Tethering (SMOLT) is a proprietary technology developed by Scanogen for the rapid and ultra-sensitive detection of biomolecules. They detect DNA, genotype DNA, diagnose cancer early, and detect infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.9M
- Last round: Grant (Sep 2025)
- Website: scanogen.com
- Phone: +1 410 944 5000
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/scanogen-2206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.